Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: Update on the Saudi experience

Bone Marrow Transplantation

Volumn 41, Issue 3, 2008, Pages 261-265

  Ayas, M ^a   Al Jefri, A ^a   Al Seraihi, A ^a   Al Mahr, M ^a   Rifai, S ^a   Al Ahmari, A ^a   Khairy, A ^a   El Hassan, I ^b   El Solh, H ^a  

^a Department of Pediatric Hematology Oncology   (Saudi Arabia)

^b Research Unit   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MESNA; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADD ON THERAPY; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYELODYSPLASIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SAUDI ARABIA; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; FANCONI ANEMIA; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; SAUDI ARABIA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 39349115864     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705903     Document Type: Article

References (19)

1. Kohli-Kumar M, Morris C, DeLaat C, Sambrano J, Masterson M, Mueller R et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050-2054.
2. Socié G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H et al Transplantation for Fanconi's anaemia: Long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249-255.
3. Ayas M, Solh H, Mustafa MM, Al-Mahr M, Al-Fawaz I, Al-Jefri A et al Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 2001; 27: 139-143.
4. Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Al-Seraihi A, Tbakhi A et al Stein cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Transplant 2005; 35: 463-466.
5. Zanis-Neto J, Flowers ME, Medeiros CR, Bitencourt MA, Bonfim CM, Setúbal DC et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 2005; 130: 99-106.
6. Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT. Fanconi anemia. Myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 2000; 117: 125-131.
7. Tischkowitz M. Dokal I. Fanconi anaemia and leukaemia-clinical and molecular aspects. Br J Haematol 2004; 126: 176-191.
8. Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Moussa E, Karaoui M et al. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation. Bone Marrow Transplant 2004; 33: 15-17.
9. Ikushima S, Hibi S, Todo S, Sawada T, Matsumoto Y, Iwami H et al. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia. Bone Marrow Transplant 1995; 16: 621-624.
10. Philpott NJ, Marsh JCW, Kumaran TO, Yardumian A, Lawler M, McCann SR et al. Successful bone marrow transplant for Fanconi anaemia in transformation. Bone Marrow Transplant 1994; 14: 151-153.
11. Ayas M, Al-Mahr M, Al-Jefri A, Rifai S, Solh H. Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence? Bone Marrow Transplant 2003; 31: 311.
12. Flowers M, Doney KC, Storb R, Deeg HJ, Sanders JE, Sullivan KM et al Marrow transplantation for Fanconi anemia with or without leukemic transformation: An update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167-173.
13. Berger R, Bernheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980; 45: 565-568.
14. Gluckman E. Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54. 431-440.
15. De La Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IAG, Rahemtulla A et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003; 32: 653-656.
16. George B, Mathews V, Shaji RV, Srivastava V, Srivastava A, Chandy M. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant 2005; 35: 341-343.
17. Tan PL, Wagner JE, Auerbach AD, DeFor TE, Slungaard A, MacMillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatric Blood and Cancer 2006; 46: 630-636.
18. Bitan M, Or R, Shapira MY, Aker M, Resnick IB, Ackerstein A et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 2006; 12: 712-718.
19. Mehta PA, Ileri T, Harris RE, Williams DA, Mo J, Smolarek T et al. Chemotherapy for myeloid malignancy in children with Fanconi anemia. Pediatr Blood Cancer 2007; 48: 668-672.